Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 20712749)

1.

Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis.

Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR.

Int J Bipolar Disord. 2014 Dec 20;2:15. doi: 10.1186/s40345-014-0015-8. eCollection 2014.

2.

Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.

Pan PY, Lee MS, Lo MC, Yang EL, Yeh CB.

BMC Psychiatry. 2014 May 19;14:145. doi: 10.1186/1471-244X-14-145.

3.

A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.

Tränkner A, Sander C, Schönknecht P.

Neuropsychiatr Dis Treat. 2013;9:101-11. doi: 10.2147/NDT.S37126. Epub 2013 Jan 18.

4.

Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.

Johnsen E, Kroken RA.

Ther Adv Chronic Dis. 2012 Nov;3(6):287-300. doi: 10.1177/2040622312462275.

5.

A decision analysis of long-term lithium treatment and the risk of renal failure.

Werneke U, Ott M, Renberg ES, Taylor D, Stegmayr B.

Acta Psychiatr Scand. 2012 Sep;126(3):186-97. doi: 10.1111/j.1600-0447.2012.01847.x. Epub 2012 Mar 9. Review.

6.

Management of bipolar depression.

Chang JS, Ha K.

Indian J Psychol Med. 2011 Jan;33(1):11-7. doi: 10.4103/0253-7176.85390.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk